Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New vaccines for disease prevention

D D Banker1

  • 1Special Reference Laboratory, Bombay Mutual Terrace, Mumbai.

Indian Journal of Medical Sciences
|October 15, 1998
PubMed
Summary

Developing new vaccines is crucial for controlling existing and emerging diseases. Biotechnology can make these vaccines cost-effective, reducing global health burdens and expenses.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Serological surveillance for HIV-l infection in Bombay.

The National medical journal of India·2018
Same author

Aureomycin in Typhoid Fever. A Preliminary Report of Clinical Trial in Four Cases.

The Indian medical gazette·2017
Same author

Typhoid Fever.

The Indian medical gazette·2017
Same author

Polymerase chain reaction based diagnosis of systemic fungal infections and sensitivity testing of the fungal isolates.

Indian journal of medical microbiology·2007
Same author

Viral hepatitis (Part-IV).

Indian journal of medical sciences·2003
Same author

Viral hepatitis (Part - III).

Indian journal of medical sciences·2003

Area of Science:

  • Vaccinology
  • Biotechnology
  • Infectious Disease Control

Background:

  • Existing vaccines are insufficient for all prevalent and novel pathogens.
  • Emerging infectious diseases pose a significant global health threat.
  • Current disease control methods are often costly and burdensome.

Purpose of the Study:

  • To highlight the necessity of novel vaccine development.
  • To explore the potential of biotechnology in vaccine production.
  • To emphasize the long-term economic and health benefits of advanced vaccines.

Main Methods:

  • Review of current vaccine technology limitations.
  • Analysis of biotechnology applications in pharmaceutical development.
  • Economic modeling of vaccine implementation.

Main Results:

  • Biotechnology offers pathways to more effective and affordable vaccines.
  • New vaccines can address unmet needs in infectious disease prevention.
  • Cost-effective vaccine strategies can significantly reduce healthcare expenditures.

Conclusions:

  • Investment in modern biotechnology is essential for future vaccine development.
  • Novel vaccines are critical for managing current and future disease outbreaks.
  • Biotechnologically-driven vaccine solutions promise substantial long-term economic and societal benefits.

Related Experiment Videos